ABSTRACT
Brachytherapy is an established modality for treating cancer of the head and neck, breast, cervix, prostate, and soft tissue sarcomas.1,2 Although technically demanding, brachytherapy techniques offer substantial advantages in dose distributions by providing a conformal geometry to tumor volumes of interest. Recent interest in brachytherapy has been enhanced by applications to prostate cancer treatment and partial breast irradiation. Both permanent and temporary high dose rate (HDR) interstitial brachytherapy treatments are currently employed in the treatment of malignant and non-malignant diseases.
